Skip to main content

Published locations for Adding elotuzumab to lenalidomide/dexamethasone can prolong survival in relapsed/refractory myeloma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adding elotuzumab to lenalidomide/dexamethasone can prolong survival in relapsed/refractory myeloma

User login

  • Reset your password
  • /content/adding-elotuzumab-lenalidomide/dexamethasone-can-prolong-survival-relapsed/refractory
  • /hematologynews/article/208455/multiple-myeloma/adding-elotuzumab-lenalidomide/dexamethasone-can
  • /oncologypractice/article/208455/multiple-myeloma/adding-elotuzumab-lenalidomide/dexamethasone-can
  • /hematology-oncology/article/208455/multiple-myeloma/adding-elotuzumab-lenalidomide/dexamethasone-can
  • /hematologytimes/article/208455/multiple-myeloma/adding-elotuzumab-lenalidomide/dexamethasone-can